This bill establishes a voluntary pilot program allowing licensed psychiatric facilities in New Jersey to temporarily convert certain adult acute beds into adult closed acute beds without changing their official license. Under this program, facilities do not need separate approval from the Department of Health to make these temporary adjustments, and the initiative will last for 24 months unless extended by the state health commissioner. Participating facilities must submit quarterly reports detailing how often and for how long they used this flexibility, and these reports will be made public online. At the end of the pilot period, the health commissioner will review the results and submit a recommendation to the Governor and Legislature on whether to continue or make the program permanent.
S 3463 requires businesses that place or refer providers of companion, health care, or personal care services in a person’s home (to individuals with disabilities or age 60+) to register as "Health Care Service Firms" and comply with new regulations, excluding existing home health care and hospice agencies. Key provisions include mandatory accreditation within 12 months of registration, annual financial statements, and tiered audit or reporting requirements based on revenue: firms receiving over $500,000 in Medicaid Personal Care Assistance revenue must submit audits every three years, while those with $10 million+ in annual gross income must audit annually. Smaller firms (under $500,000 in Medicaid revenue and $1-10 million in gross income) must submit third-party reports detailing insurance, litigation, and regulatory actions. The Division of Consumer Affairs will enforce these rules to ensure transparency and quality in the care sector.
This bill allows doctors in New Jersey to prescribe Schedule II controlled substances, such as certain pain medications, through telemedicine and telehealth without requiring an in-person visit. It permits providers to use digital tools like video calls or asynchronous messaging to evaluate patients, provided they have already reviewed the patient's medical records and determined that remote care meets the same standard of care as an in-person appointment. The legislation also mandates that patients be informed if their provider is not a physician and must be given the option to request a consultation with a doctor, while ensuring all telehealth interactions are properly documented and referrals for in-person care are made when necessary.
This bill allows licensed residential substance use disorder treatment facilities in New Jersey to offer residential mental health services to patients with co-occurring conditions. To qualify, these facilities must have a formal written partnership with a hospital that provides ongoing clinical oversight, medical staffing, and quality assurance. The legislation requires these partnerships to include shared treatment protocols, 24-hour psychiatric and medical consultation, and clear procedures for transferring patients to inpatient care when necessary. Facilities meeting these criteria must file their partnership agreements with the Department of Health and remain subject to existing state regulations.
This bill creates the School-Based Partnerships for Access and Resilience for Kids program within the Department of Children and Families to support student mental health. It requires school districts, charter schools, and renaissance schools to develop specific mental health support programs that connect students with high behavioral health needs to the new SPARK program navigator. The SPARK program, operated by the New Jersey Pediatric Psychiatry Collaborative, will provide same-day psychiatric consultations, referrals to community providers, and assistance with school re-entry after a mental health crisis. Access to these services is limited to students in kindergarten through grade 12 and requires written consent from a parent or legal guardian. Additionally, the bill mandates that schools have designated staff or formal agreements with external providers to ensure ongoing counseling support for their students.
This New Jersey bill introduces a new fee for employers who have at least 50 employees receiving Medicaid health coverage. The fee amount varies based on company size, charging $325, $525, or $725 per covered employee and their dependents depending on whether the employer has between 50-249, 250-499, or 500 or more Medicaid recipients. Employers with employees who have developmental, intellectual, or permanent physical disabilities are exempt from paying this charge. The revenue generated from these fees is intended to help cover the costs of the State Medicaid program.
This bill directs New Jersey's Department of Children and Families to improve access to mental health care for children and their families. It requires the department to expand services through the New Jersey Pediatric Psychiatry Collaborative, which includes adding telehealth options, providing real-time psychiatric support to pediatric doctors, and offering better training and referral systems. The legislation also mandates greater transparency by setting specific performance goals for service providers, making contract results public, and launching a public awareness campaign to help families find care. Additionally, the bill establishes a new requirement for hospitals and clinics to report standardized data on how often children seek psychiatric or behavioral health services.
This bill requires all corn masa flour and wet corn masa products sold in New Jersey to be fortified with folic acid to help reduce the risk of neural tube defects, which disproportionately affect Latino communities. Manufacturers must add specific amounts of folic acid to dry flour and wet products and clearly label these ingredients on nutrition facts panels. The law allows the state health commissioner to grant exemptions for specific products or companies if necessary. By making these changes, the legislation aims to ensure that dietary staples common in Central and South American cuisines provide essential nutritional benefits comparable to other fortified grains.
This New Jersey bill mandates that health insurance plans and Medicaid cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law applies to hospital service, medical service, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. A key provision ensures that these specific Alzheimer's treatments are not subject to step therapy requirements, meaning patients can access them without needing to try other medications first. Additionally, the coverage must be provided at the same level as benefits for other medical conditions.
This bill permanently extends pay parity for telemedicine and telehealth services in New Jersey, requiring health insurance carriers to reimburse providers at the same rates as in-person care. It directly affects insurance companies, healthcare providers, and patients by mandating that out-of-pocket costs like deductibles and copayments for virtual visits cannot exceed those for in-person appointments. The legislation also prohibits insurers from restricting telehealth platforms, limiting service locations, or denying coverage for routine remote monitoring if the same care would be covered in person. Additionally, carriers must continue to allow patients to choose between in-person and virtual care rather than forcing telehealth as a substitute.
